HBV induces HCC through a variety of mechanisms such as genomic instability, the activation of cancer-promoting pathways (e.g., Wnt/beta-Catenin and PI3K/Akt), and epigenetic modifications. Here, AKT1 is linked to hepatocellular carcinoma.